Please login to the form below
23
Revenue 2017Teva
The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Teva's 2013 sales performance.
Pharma funding and M&A in 2020
Indeed, this has been several years in the making, with former Teva chairman Dr Yitzhak Peterburg saying back in 2017 that he was competing not only with the Novartises of the
Lundbeck drops Parkinson’s drug acquired in €905m deal
The deal was signed by former chief executive Anders Götzsche, who ran the company on an interim basis after former CEO Kåre Schultz was poached by Teva and before current CEO ... Amgen, Eli Lilly and Teva – as well as a $400m purchase of Abide
Trump calls on FDA to cut ‘red tape’ as coronavirus drug trials gather pace
Meanwhile, Bayer and Teva have said they will donate millions of tablets of the drug to the US for testing and compassionate-use purposes.
Modest meeting sees only two drugs recommended by CHMP
The drug was third to market in the class, coming behind first place winner Aimovig (erenumab) from Amgen and second entrant Ajovy (fremanezumab) from Teva.
Biohaven gets FDA approval for migraine drug Nurtec ODT
A successful outcome in those studies would make the drug a potential competitor to three CGRP inhibitors given by subcutaneous injection – Amgen/Novartis’ Aimovig (erenumab), Teva’s Ajovy (fremanezumab) and
Data provided by GlobalData
GlobalData is the premier source of research and consulting solutions for the pharmaceutical and medical device industries. With the combined expertise of more than 600 researchers, market analysts and consultants, we deliver high-quality, accurate and transparent industry insight that helps our clients to achieve growth and increase business value.
To find out more about how our research and consulting solutions can help you, please visit healthcare.globaldata.com
For more details on the data and methodology used to create the Top Pharma Lists, please visit PMLiVE's Top Pharma List - Methodology
COVID-19 Updates and Daily News
Featured jobs
- After the watershed: the dos and don’ts of digital KPIs in a post-pandemic world
- Imperial College London to lead major coronavirus home testing programme
- Regeneron says antibody for COVID-19 could be ready this year
- Moderna’s coronavirus vaccine hits first objectives
- UK’s new COVID-19 trial initiative fast-tracks BerGenBio’s bemcentinib
- Novartis to test canakinumab for COVID-19, as IL-6 trial disappoints
- AZ secures capacity for one billion coronavirus vaccine doses
- EMA starts review of MorphoSys’ tafasitamab for lymphoma
- Gilead, Galapagos dip on mixed ulcerative colitis data
- Roche makes protein degradation play with $135m Vividion deal
- Octapharma cleared to start phase 3 trial of Octagam in COVID-19
- UK government expands coronavirus testing criteria
PMHub
Impetus Digital
Impetus Digital has offered virtual advisory boards, clinical trial investigator consortiums, co-author publication working groups, steering committees, and medical education...
Latest intelligence
- OPEN Health attend EB World Congress—building on momentum and strength in numbers for epidermolysis bullosa
- Ben Speller shares his thoughts on the value of disease specific congresses...
- OPEN Health use PR to support clinical trial recruitment
- International Clinical Trials Day finds clinical research in the spotlight like never before, with any news coming from the many studies into potential vaccines and treatments for SARS-CoV-2...
- Covid-19: what could it mean for the diabetic population?
- Steve How and Oli Hudson, of Wilmington Healthcare, assess the scale of the diabetes crisis and how coronavirus might impact on it...
Quick links
Infographics
